Cor Vasa 2016, 58(6):e584-e590 | DOI: 10.1016/j.crvasa.2015.11.001

The impact of diabetes on electrocardiographic ST resolution and clinical outcome of acute ST elevation myocardial infarction following fibrinolytic therapy

Mir Milad Pourmousavia, Arezou Tajlila, Behzad Rahimi Darabadb, Laleh Pourmousavia, Leili Pourafkaric, Samad Ghaffaria,*
a Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
b Reproductive Health Research Center, Urmia University of Medical Sciences, Urmia, Iran
c University at Buffalo, United States

Objective: To investigate the association of diabetes with ST segment resolution and clinical outcomes after fibrinolysis in patients with first ST elevation myocardial infarction (STEMI).

Methods and results: Clinical information from 275 consecutive patients with first STEMI, who received streptokinase within six hours of chest pain initiation, was collected prospectively. ST resolution ≥ 50%, ninety minutes after fibrinolysis was considered as a sign of successful reperfusion. Association of diabetes with the risk of reperfusion failure, development of heart failure and in-hospital mortality was determined before and after controlling for other coronary risk factors.
ST resolution ≥ 50% was present in 45.1% of non-diabetics and 48.7% of diabetics (p = 0.1). Heart failure and in-hospital mortality were more common in diabetics (25.7% vs. 14.8%, p = 0.03 and 17.8% vs. 8.4%, p = 0.03, respectively). Diabetics were more likely to have three-vessel disease in coronary angiography (23% vs. 8%, p < 0.001). After controlling for baseline characteristics, diabetes was not independently associated with reperfusion failure and major adverse cardiac events, including heart failure and in-hospital mortality.

Conclusions: ST resolution is not affected by the presence of diabetes. Although diabetics have higher prevalence of heart failure and in-hospital mortality after treatment of STEMI with streptokinase, their poor outcome is most likely due to higher burden of simultaneous coronary risk factors.

Keywords: Diabetes mellitus; Electrocardiography; Myocardial infarction; Thrombolysis

Received: September 3, 2015; Revised: October 30, 2015; Accepted: November 1, 2015; Published: December 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pourmousavi MM, Tajlil A, Darabad BR, Pourmousavi L, Pourafkari L, Ghaffari S. The impact of diabetes on electrocardiographic ST resolution and clinical outcome of acute ST elevation myocardial infarction following fibrinolytic therapy. Cor Vasa. 2016;58(6):e584-590. doi: 10.1016/j.crvasa.2015.11.001.
Download citation

References

  1. D. Mozaffarian, E.J. Benjamin, A.S. Go, et al., Heart Disease and Stroke Statistics-2015 update: a report from the American Heart Association, Circulation 129 (2014) e28-e292. Go to PubMed...
  2. S. Sattur, B. Sarwar, T.J. Sacchi, S.J. Brener, Correlation between markers of reperfusion and mortality in ST-elevation myocardial infarction: a systematic review, Journal of Invasive Cardiology 26 (2014) 587-595. Go to PubMed...
  3. S. Rao, B.S. Patil, Predictors of failed thrombolysis in acute myocardial infarction, International Journal of Biomedical Research 3 (2012) 239-244. Go to original source...
  4. J.R. Timmer, J.P. Ottervanger, M.J. de Boer, et al., Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial, Archives of Internal Medicine 167 (2007) 1353-1359. Go to original source... Go to PubMed...
  5. N. Danchin, E. Puymirat, P.G. Steg, et al., Five-year survival in patients with ST-segment elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 cohort, Circulation (2014), http://dx.doi.org/10.1161/CIRCULATIONAHA.113.005874. Go to original source... Go to PubMed...
  6. P.W. Armstrong, D. Collen, E. Antman, Fibrinolysis for acute myocardial infarction: the future is here and now, Circulation 107 (2003) 2533-2537. Go to original source... Go to PubMed...
  7. L. Bhatia, G.J. Clesham, D.R. Turner, Clinical implications of ST-segment non-resolution after thrombolysis for myocardial infarction, Journal of the Royal Society of Medicine 97 (2004) 566-570. Go to original source... Go to PubMed...
  8. J.A. de Lemos, E. Braunwald, ST segment resolution as a tool for assessing the efficacy of reperfusion therapy, Journal of the American College of Cardiology 38 (2001) 1283-1294. Go to original source... Go to PubMed...
  9. R. Schroder, Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction, Circulation 110 (2004) e506-e510. Go to original source... Go to PubMed...
  10. L.F. Hsu, K.H. Mak, K.W. Lau, et al., Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis, Heart (British Cardiac Society) 88 (2002) 260-265. Go to original source... Go to PubMed...
  11. M. Chiha, M. Njeim, E.G. Chedrawy, Diabetes and coronary heart disease: a risk factor for the global epidemic, International Journal of Hypertension 2012 (2012) 697240. Go to original source... Go to PubMed...
  12. M. Masoomi, S. Samadi, M. Sheikhvatan, Thrombolytic effect of streptokinase infusion assessed by ST-segment resolution between diabetic and non-diabetic myocardial infarction patients, Cardiology Journal 19 (2012) 168-173. Go to original source... Go to PubMed...
  13. B.G. Angeja, J. de Lemos, S.A. Murphy, et al., Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy, American Heart Journal 144 (2002) 649-656. Go to original source... Go to PubMed...
  14. M.N. Zairis, A.G. Lyras, S.S. Makrygiannis, et al., Type 2 diabetes and intravenous thrombolysis outcome in the setting of ST elevation myocardial infarction, Diabetes Care 27 (2004) 967-971. Go to original source...
  15. M.A.R. Chowdhury, A.K.M.M. Hossain, S.R. Dey, et al., A comparative study on the effect of streptokinase between diabetic and non-diabetic myocardial infarction patients, Bangladesh Journal of Pharmacology 3 (2008) 1-7. Go to original source...
  16. S.R. Park, Y.R. Kang, M.K. Seo, et al., Clinical predictors of incomplete ST-segment resolution in the patients with acute ST segment elevation myocardial infarction, Korean Circulation Journal 39 (2009) 310-316. Go to original source... Go to PubMed...
  17. S. Dobrzycki, M. Kozuch, K. Kaminski, et al., High cholesterol in patients with ECG signs of no-reflow after myocardial infarction, Roczniki Akademii Medycznej w Bialymstoku (1995) 48 (2003) 118-122. Go to PubMed...
  18. K.H. Mak, D.J. Moliterno, C.B. Granger, et al., Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries, Journal of the American College of Cardiology 30 (1997) 171-179. Go to original source... Go to PubMed...
  19. M. Tomasevic, T. Kostic, S. Apostolovic, et al., Comparative effect of streptokinase and alteplase on electrocardiogram and angiogram signs of myocardial reperfusion in ST segment elevation acute myocardial infarction, Srpski arhiv za celokupno lekarstvo 136 (2008) 481-487. Go to original source... Go to PubMed...
  20. H.L. Kim, S.H. Kang, C.H. Yoon, et al., Differential prognostic impacts of diabetes over time course after acute myocardial infarction, Journal of Korean Medical Science 28 (2013) 1749-1755. Go to original source... Go to PubMed...
  21. G. de Gevigney, D. Cao, E. Macfadden, et al., Do differences in baseline characteristics or in management account for the poorer in-hospital and subsequent outcome after myocardial infarction in diabetics? Data from a large unselected cohort, Acta Cardiologica 57 (2002) 187-196. Go to original source... Go to PubMed...
  22. J.R. Timmer, J.P. Ottervanger, K. Thomas, et al., Long-term, cause-specific mortality after myocardial infarction in diabetes, European Heart Journal 25 (2004) 926-931. Go to original source... Go to PubMed...
  23. P. Grant, Diabetes mellitus as a prothrombotic condition, Journal of Internal Medicine 262 (2007) 157-172. Go to original source... Go to PubMed...
  24. A. Undas, I. Wiek, E. Stêpień, et al., Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome, Diabetes Care 31 (2008) 1590-1595. Go to original source... Go to PubMed...
  25. M.I. Worthley, F.M. Shrive, T.J. Anderson, M. Traboulsi, Prognostic implication of hyperglycemia in myocardial infarction and primary angioplasty, American Journal of Medicine 120 (2007) 643.e1-7. Go to original source... Go to PubMed...
  26. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group, Lancet 343 (1994) 311-322.
  27. C. Kocas, O. Abaci, G.S. Halil, et al., Admission hyperglycemia is associated with failed reperfusion following fibrinolytic therapy in patients with STEMI: results of a retrospective study, American Journal of Cardiovascular Drugs 15 (2015) 35-42. Go to original source... Go to PubMed...
  28. C.F. Lundergan, J.S. Reiner, W.F. McCarthy, et al., Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries, Journal of the American College of Cardiology 32 (1998) 641-647. Go to original source... Go to PubMed...
  29. S.L. Woodfield, C.F. Lundergan, J.S. Reiner, et al., Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience, Journal of the American College of Cardiology 28 (1996) 1661-1669. Go to original source... Go to PubMed...
  30. Y.Y. Lee, M.H. Tee, Y. Zurkurnai, et al., Thrombolytic failure with streptokinase in acute myocardial infarction using electrocardiogram criteria, Singapore Medical Journal 49 (2008) 304-310.
  31. D.K. McGuire, H. Emanuelsson, C.B. Granger, et al., Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study, European Heart Journal 21 (2000) 1750-1758. Go to original source... Go to PubMed...
  32. M.O. Gore, M.J. Patel, M. Kosiborod, et al., Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction, Circulation Cardiovascular Quality and Outcomes 5 (2012) 791-797. Go to original source... Go to PubMed...
  33. H. Vihonen, I. Tierala, M. Kuisma, et al., Ultra-acute increase in blood glucose during prehospital phase is associated with worse short-term and long-term survival in ST-elevation myocardial infarction, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 22 (2014) 30. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.